Insight

Another important developmental study coming out of SWOG

Photo of Virginia Sun from X

Jun 26, 2024, 02:26

Another important developmental study coming out of SWOG

Benjamin Toll, Associate Director of Education at MUSC Hollings Cancer Center, shared on X:

“Another important developmental study coming out of SWOG in ACS Journal Cancer:

SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer – Sun – 2024 – Cancer – Wiley Online Library

Source: Benjamin Toll/X

SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer

Authors: Virginia Sun PhD, RN, Katherine A. Guthrie PhD, Tracy E. Crane PhD, RDN, Kathryn B. Arnold MS, Sarah Colby MS, Sarah G. Freylersythe BS, Christa Braun-Inglis DNP, APRN, FNP-BC, Roxanne Topacio CCRP, Craig A. Messick MD, Joseph C. Carmichael MD, Andrew A. Muskovitz MD, Mohammed Nashawaty MD, Madhuri Bajaj MD, Stacey A. Cohen MD, Devin C. Flaherty DO, PhD, Mark A. O’Rourke MD, Lee Jones MBA, Robert S. Krouse MD, Cynthia A. Thomson PhD, RDN

ACS Journal Cancer Andrew A. Muskovitz cancer Christa Braun-Inglis Craig A. Messick Cynthia A. Thomson Devin C. Flaherty Joseph C. Carmichael Katherine A. Guthrie Kathryn B. Arnold Lee Jones Madhuri Bajaj Mark A. O’Rourke Mohammed Nashawaty MUSC Hollings Cancer Center OncoDaily Oncology Robert S. Krouse Roxanne Topacio Sarah Colby Sarah G. Freylersythe Stacey A. Cohen SWOG Tracy E. Crane Virginia Sun

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage